CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
CD-ResVir focuses on developing a preventive nasal spray to combat respiratory infections by using self-assembling cyclodextrin conjugates. These systems target viruses like SARS-CoV-2 through multivalent interactions, enhancing their effectiveness against pathogens.
The covid-19 pandemic has arisen awareness about the importance of developing tools to fight viral infection.
However, there is still a lack of products to be used by the public as preventive systems against respiratory pathogens.
Different systems have been developed to target SARS-CoV-2 using its affinity for different ligands.
However, a multivalent presentation of these ligands is necessary to overcome their low affinity, which often implies complex structures difficult to synthesise and cha…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Hungary, Budapest
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
University of Naples Federico II
Italy, Naples
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
